Typhoid Vaccine Wyeth - Biotech, Pharma and Life Science Channel

17:59 EDT 23rd October 2014 | BioPortfolio

PubMed Articles [1527 Associated PubMed Articles listed on BioPortfolio]

Hepatitis B in Pregnancy.

Hepatitis B Virus (HBV) infects over 2 billion people worldwide, with approximately 360 million chronically infected. It results in substantial morbidity and mortality, with an estimated 600,000 death...

Disease Surveillance Methods Used in the 8-Site MAL-ED Cohort Study.

Describing the early life associations between infectious disease episodes and growth, cognitive development, and vaccine response in the first 2 years of life is one of the primary goals of the Etiol...

Methods of Analysis of Enteropathogen Infection in the MAL-ED Cohort Study.

Studies of diarrheal etiology in low- and middle-income countries have typically focused on children presenting with severe symptoms to health centers and thus are best equipped to describe the pathog...

Assessment of Environmental Enteropathy in the MAL-ED Cohort Study: Theoretical and Analytic Framework.

Individuals in the developing world live in conditions of intense exposure to enteric pathogens due to suboptimal water and sanitation. These environmental conditions lead to alterations in intestinal...

Evaluating Associations Between Vaccine Response and Malnutrition, Gut Function, and Enteric Infections in the MAL-ED Cohort Study: Methods and Challenges.

Most vaccine assessments have occurred in well-nourished populations of higher socioeconomic status. However, vaccines are often used in populations with high incidences of malnutrition and infections...

Bhaktapur, Nepal: The MAL-ED Birth Cohort Study in Nepal.

The Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development (MAL-ED) cohort study site in Nepal is located in the Bhaktapur...

Support for HPV Vaccination Mandates for Both Females and Males.

To examine college students' support for HPV vaccination mandates for school-aged youth and examine perceptions and behavioral factors associated with vaccine mandate support for both boys and girls.

The Estimated Impact of Human Papillomavirus Vaccine Coverage on the Lifetime Cervical Cancer Burden Among Girls Currently Aged 12 Years and Younger in the United States.

Using a previously published dynamic model, we illustrate the potential benefits of human papillomavirus vaccination among girls currently 12 years or younger in the United States. Increasing vaccine ...

Shortening Treatment for Tuberculosis - Back to Basics.

With approximately 8 million incident cases and 1.3 million deaths each year, increasing drug resistance, and exacerbating coexisting conditions such as the human immunodeficiency virus-acquired immun...

Sex Differences Among College Students in Awareness of the HPV Vaccine and Vaccine Options.

Objectives: To explore awareness of HPV and use of HPV vaccines (Gardasil® and Cervarix®) by college students. Participants: The sample was comprised of 817 undergraduates at two northeastern U.S. u...

News Articles [2513 Associated News Articles listed on BioPortfolio]

Vaxart Accelerates Development of Ebola Tablet Vaccine

Start of Clinical Trials Anticipated in Early 2015 Based on Recent Meeting with FDA Vaxart’s Ebola vaccine candidate was protective against challenge in ...

Building a Universal Flu Vaccine

Developing a universal flu vaccine requires a two part strategy targeted at the surface of the flu virus and it’s unchanging core At Last week’s World Vaccine Congress 2014, Vaccine Nation...

Interview: The Problem with Cancer Vaccines

You can’t treat a heterogeneous disease with a homogeneous treatment. That was the takeawy message from Vaccinogen’s founder at the World Vaccines Congress Europe Vaccine Nation caught u...

The Problem with Cancer Vaccines

You can’t treat a heterogeneous disease with a homogeneous treatment. That was the takeawy message from Vaccinogen’s founder at the World Vaccines Congress Europe Vaccine Nation caught u...

Pharma pulls together for Ebola vaccine; JnJ invests $200m

Vaccination for nicotine addiction being developed

A Virginia Tech professor is working on a vaccine that could help smokers conquer their nicotine addiction, making many smoking-related diseases and deaths relics of the 21st century.

Pharma pulls together for Ebola vaccine; J&J invests $200m

But the current Ebola crisis has changed that, and Dr Stoffels said he has been in frequent communication with GKS's CEO.

Human trial of second investigational Ebola vaccine candidate under way

Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

Which is the right flu vaccine for you?

The best way to avoid the flu is spending the months from fall until spring in a solitary bunker, communicating with other people only electronically. The second best way is getting the flu vaccine. T...

BRIEF-Bavarian Nordic to expand collaboration with Janssen

COPENHAGEN, Oct 23 (Reuters) - Danish biotech company Bavarian Nordic A/S said late on Wednesday: ** it has agreed with Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of Johnson & J...

Events [0 Results]

None

Companies [88 Associated Companies listed on BioPortfolio]

Mucosis B.V.

Mucosis B.V. (Mucosis) is a clinical-stage biotechnology company using a proprietary technology platform to develop next-generation needle-free human vaccines for infectious disea...

The Vaccine & Gene Therapy Institute of Florida

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied fo...

Shoo the Flu

The flu, also called influenza, is a contagious disease that spreads by coughing, sneezing and close contact. Flu symptoms include fever/chills, sore throat, muscle aches, fatigue...

Redbiotec

Redbiotec is a privately held Swiss biopharmaceutical company founded in 2006 and based in Zurich-Schlieren. The company uses its proprietary rePAX® co-expression tec...

Biosceptre

Biosceptre has identified a pan-cancer target, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs di...

Smithers Avanza

Smithers Avanza is a contract research organization known for superior quality, on-time delivery, flexibility, and responsiveness. Our laboratories support the pharmaceutical and ...

TapImmune Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

PaxVax Inc.

PaxVax is a privately held specialty vaccine company founded in 2007. PaxVax is focused on traveler vaccines with an emerging pipeline in biodefense coupled with a social mission ...

Clinical Trials [2057 Associated Clinical Trials listed on BioPortfolio]

Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)

The purpose of this study is to evaluate the safety, tolerability, and immune response of an investigational vaccine being evaluated to reduce the incidence of diphtheria, pertussis, tetan...

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. This Phase IV, observer-blind study is designed to evaluate the safety and i...

ZOSTAVAX® in Renal Transplant Patients

The purpose of this study is to test the safety of a licensed zoster vaccine, ZOSTAVAX® (Zoster Vaccine Live) in 40 subjects, age 18 years or older, with chronic kidney disease (CKD) who ...

Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults

This study is designed to evaluate safety, reactogenicity, immunogenicity, and efficacy of GSK Biological's malaria candidate vaccine 257049 administered as standard doses at 0 and 1 month...

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

Background: - Many cancers produce two proteins, carcinoembryonic antigen (CEA) and mucin-1 (MUC-1). - The PANVAC-V priming vaccine and PANVAC-F boosting vaccine contain human gene...

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

A study in two parts (Part A and Part B) to evaluate the responsiveness of various biomarkers of immunity to Varicella-Zoster Virus (VZV) following repeated immunizations with heat treated...

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

This randomized phase II trial studies how well giving vaccine therapy with or without bevacizumab works in treating patients with recurrent glioblastoma multiforme that can be removed by ...

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children

The purpose of this trial is to demonstrate the acceptable safety profile and the immunological non-inferiority of the FLU D-QIV vaccine manufactured with this investigational process (FLU...

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' HZ/su vaccine in subjects' ≥ 50 years of age (YOA) who previously have had Herpes Zoster (HZ). ...

Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission

This randomized phase I trial studies the side effects and best way to give vaccine therapy together with basiliximab in treating patients with acute myeloid leukemia (AML) in complete rem...

Videos

What makes a conjugated vaccine different from a non-conjugated

What makes a conjugated vaccine by Kevin M. windisch MD FAAP and Sparks Pediatric and adolescent medicine.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Typhoid Vaccine Wyeth market research data and corporate reports here

Channels Quicklinks